Article Text

other Versions

Risk factor management after acute coronary syndromes
  1. Chiara Melloni (chiara.melloni{at}
  1. Duke Clinical Research Institute, United States
    1. L Kristin Newby (newby001{at}
    1. Duke Clinical Research Institute, United States


      Considerable resources in most healthcare systems and hospitals are devoted to measuring, improving and ensuring quality of care. In no other disease area is this a more prominent focal point than in cardiovascular disease. Randomized clinical trials have clearly proven benefits from treatment with a number of therapies for patients presenting with acute coronary syndromes, and their results are the foundation of guidelines recommendations worldwide.1-5 These recommended treatments range from inexpensive, noninvasive and relatively low risk interventions, such as the use of aspirin, to more invasive and/or higher risk interventions like coronary angiography and revascularization.

      Statistics from

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      Linked Articles